Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Clinical Drug Investigation|December 14, 2006
Psychiatric symptoms induced by antiviral therapy in chronic hepatitis C: comparison between interferon-alpha-2a and interferon-alpha-2bSergio Neri, Davide Pulvirenti, Gaetano Bertino
Clinical Therapeutics|April 28, 2009
Drug rash with eosinophilia and systemic signs syndrome in a patient with multiple sclerosisAngelo Caruso, Rosario Vecchio, Francesco Patti, et al.
Journal of Gastroenterology|August 31, 2002
A hyperdynamic portal syndrome with ascites after endoscopic laser treatmentSergio Neri, Dario Ierna, Barbara Mauceri, et al.
Neuropsychobiology|April 23, 2003
L-carnitine decreases severity and type of fatigue induced by interferon-alpha in the treatment of patients with hepatitis CSergio Neri, Giovanni Pistone, Barbara Saraceno, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|December 2, 2004
Interleukin-2 plus ribavirin versus interferon-alpha-2b plus ribavirin in patients with chronic hepatitis C who did not respond to previous interferon-alpha-2b treatmentMariano Malaguarnera, Giovanni Pistone, Sergio Neri, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|January 1, 2005
Efficacy of human recombinant erythropoietin plus IFN-alpha in patients affected by chronic hepatitis CIgnazio Di Fazio, Massimo Motta, Salvatore Musumeci, et al.
Angiology|June 16, 2010
Study on unrecognized peripheral arterial disease (PAD) by ankle/brachial index and arterial comorbidity in Catania, Sicily, ItalySalvatore Santo Signorelli, Massimiliano Anzaldi, Valerio Fiore, et al.
European Journal of Ophthalmology|January 19, 2024
Vision loss due to atypical bilateral edema of the optic nerve in a patient with hereditary angioedema: A case reportNiccolò Castellino, Edoardo Dammino, Davide Scollo, et al.
Digestive Diseases and Sciences|October 17, 2007
Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndromeSergio Neri, Davide Pulvirenti, Mariano Malaguarnera, et al.
Cytokine|May 19, 2012
Patients with unrecognized peripheral arterial disease (PAD) assessed by ankle-brachial index (ABI) present a defined profile of proinflammatory markers compared to healthy subjectsSalvatore Santo Signorelli, Massimiliano Anzaldi, Valerio Fiore, et al.
Pageof 4